Evidence map›Paper›PMID 39546388›Full record

ArticleChemSusChem2025

Unfolding Electrolyzer Characteristics to Reveal Solar-to-Chemical Efficiency Potential: Rapid Analysis Method Bridging Electrochemistry and Photovoltaics.

Oleksandr Astakhov, Thérèse Cibaka, Lars Wieprecht, Uwe Rau, Tsvetelina Merdzhanova

Abstract read
In one paragraph

Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Oleksandr AstakhovPhotovoltaics (IMD-3), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.ORCID https://orcid.org/0000-0001-8499-058X
Thérèse CibakaPhotovoltaics (IMD-3), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.ORCID https://orcid.org/0009-0003-3558-4827
Lars WieprechtPhotovoltaics (IMD-3), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
Uwe RauPhotovoltaics (IMD-3), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.ORCID https://orcid.org/0000-0003-3526-3081
Tsvetelina MerdzhanovaPhotovoltaics (IMD-3), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.ORCID https://orcid.org/0000-0003-0902-6330

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of photovoltaic-electrochemical (PV-EC) systems for energy storage and industry decarbonization requires multidisciplinary collaborative efforts of different research groups from both photovoltaic and electrochemical research communities. Consequently, the evaluation of the solar-to-chemical or solar-to-fuel efficiency of a new electrolyzer (EC) as a part of a PV-EC system is a time-consuming task that is challenging in a routine optimization loop. To address this issue, a new rapid assessment method is proposed. This method employs power balance requirements to unfold the input EC characteristics into the parameter space of PV-EC systems. The system parameters, composed with the EC output characteristics, yield the solar-to-chemical efficiency attainable by the electrolyzer in combination with any PV device under any irradiance at any relative PV-to-EC scaling and any mode of power coupling. This comprehensive overview is achieved via a mathematically simple conversion of the EC characteristics in any spreadsheet software. The method, designed to streamline the development and minimize the efforts of both the photovoltaic and electrochemical communities, is demonstrated via the analysis of CO

Indexed as

ElectrochemistrySolar fuelsSolar-to-chemical efficiencySolar-to-fuel efficiencySustainable Chemistry

Identifiers

PMID39546388
PMCPMC11960588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.